Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Governance

Register of members, reviewers and correspondents

207 entries across the board, the assessment committee, the secretariat, the external reviewer register, specialist advisers, comment-period correspondents and evidence contributors.

Declared interests are published in full for every entry. A declaration is not a disqualification and the Institute states so on every submission form.

External reviewers are named against their domain rather than against individual documents, a decision taken because per-document attribution would deter reviewers from recording objections the assessment committee did not adopt. The trade-off is published on the register policy disposition page so that it is visible.

Register entries

207 documents · page 1 of 6
  • CEI-RG-004Board of TrusteesTrustee, Chair of the Analytical Standards Committeesince 2023

    An analytical chemist who spent two decades developing and validating stability-indicating methods for peptide and protein products. She is the principal author of the Institute's COA minimum data standard and of the…

    Independent consultant; formerly Head of…
  • CEI-RG-005Board of TrusteesTrusteesince 2024

    A pharmacist and clinical pharmacologist whose research concerns medication safety in populations obtaining medicines outside regulated supply. He argued successfully that the Institute should publish supplier dossiers…

    Associate Professor of Pharmacy Practice
  • CEI-RG-002Board of TrusteesDeputy Chair, Board of Trusteessince 2023

    A public-health physician with a background in evidence appraisal for population-level commissioning. Her contribution to the Institute's framework is the requirement that every assessment state the population in which…

    Consultant in Public Health Medicine
  • CEI-RG-008Board of TrusteesTrustee, Patient and Public Involvement leadsince 2024

    Responsible for ensuring that the Institute's comment periods are genuinely open to people who use the compounds it assesses, rather than only to professionals. She has argued, against some internal resistance, that a…

    Consultant Physician in Metabolic Medicine
  • CEI-RG-007Board of TrusteesTrustee, Honorary Treasurersince 2023

    Responsible for the Institute's finances and for the sponsorship-disclosure architecture. She established the rule that no sponsor may exceed twenty per cent of annual income and that any sponsor whose contribution…

    Chartered accountant; charity finance sector
  • CEI-RG-001Board of TrusteesChair, Board of Trusteessince 2023

    A clinical pharmacologist whose career was spent in regulatory assessment and in the methodology of benefit–risk evaluation. She chaired a national medicines committee for nine years and has written extensively on the…

    Emeritus Professor of Clinical…
  • CEI-RG-006Board of TrusteesTrusteesince 2024

    A hepatologist whose clinical research concerns metabolic dysfunction-associated steatotic liver disease and the reliability of histological endpoints. She led the Institute's decision to record, for every histological…

    Professor of Hepatology
  • CEI-RG-003Board of TrusteesTrustee, Chair of the Audit and Conflicts Committeesince 2023

    A lawyer whose practice concerned regulatory and research-integrity matters. He designed the Institute's conflicts-of-interest regime, including the rule that a declared interest in a compound removes a reviewer from…

    Former Chair, national research-integrity…
  • CEI-RG-015Assessment CommitteeAssessment Committee member, analytical standardssince 2024

    Contributes the analytical-characterisation sections of the monographs and reviews every submitted third-party report for method adequacy. She identified the systematic problem, recorded across several monographs, that…

    Analytical Scientist, accredited testing…
  • CEI-RG-016Assessment CommitteeAssessment Committee member, nephrologysince 2024

    Responsible for renal assessments, including the Institute's convention of reporting annual eGFR slope alongside any composite kidney endpoint on the ground that slope is less vulnerable to competing-risk distortion in…

    Consultant Nephrologist
  • CEI-RG-010Assessment CommitteeDeputy Chair, Assessment Committeesince 2023

    Chairs assessments from which the Committee Chair is recused, which in practice means the entire incretin series. His contribution is the Institute's treatment of trials stopped early for efficacy: they are extracted in…

    Consultant Cardiologist; Reader in…
  • CEI-RG-013Assessment CommitteeAssessment Committee member, safetysince 2024

    Responsible for adverse-event extraction and for the Institute's convention that an incidence figure is reported with the trial, dose and duration from which it comes, never as a bare percentage. She also authored the…

    Consultant in Pharmacovigilance
  • CEI-RG-012Assessment CommitteeAssessment Committee member, clinical pharmacologysince 2023

    Responsible for the pharmacokinetic sections of the monograph series, including the decision to record explicitly where a parameter has not been characterised in humans rather than importing an animal value. He has…

    Clinical Pharmacologist, teaching hospital
  • CEI-RG-017Assessment CommitteeAssessment Committee member, neuropsychiatric outcomessince 2025

    Responsible for assessments in the neuropsychiatric indications, including the addiction and cognition groups. She authored the Institute's distinction between a low certainty rating arising from an absence of studies…

    Consultant Psychiatrist
  • CEI-RG-011Assessment CommitteeLead Statistician, Assessment Committeesince 2023

    Responsible for every effect estimate and confidence interval the Institute reproduces, and for the rule that an estimate is reported on the scale on which it was measured before any standardisation. She insisted that…

    Senior Statistician, independent
  • CEI-RG-018Assessment CommitteeAssessment Committee member, respiratory and sleepsince 2025

    Responsible for the sleep-apnoea assessments and for the observation, recorded in several documents, that centrally scored polysomnographic endpoints support a higher certainty rating than symptom-only respiratory…

    Consultant in Respiratory and Sleep Medicine
  • CEI-RG-019Assessment CommitteeAssessment Committee member, methodssince 2024

    Responsible for the search strategies underlying the synthesis series and for the requirement that every synthesis publish its search strings, database coverage and screening decisions in full, so that a reader can…

    Senior Research Fellow, evidence synthesis
  • CEI-RG-009Assessment CommitteeChair, Assessment Committeesince 2023

    Chairs the committee that ratifies every certainty rating the Institute publishes. Her methodological position, applied consistently across the monograph series, is that an active-controlled non-inferiority result and a…

    Professor of Diabetes and Endocrinology
  • CEI-RG-014Assessment CommitteeAssessment Committee member, chemistrysince 2023

    Responsible for the identification sections of the monograph series. Her rule, applied throughout, is that where a structure has not been published the monograph says "not disclosed" rather than reproducing an unsourced…

    Professor of Medicinal Chemistry
  • CEI-RG-020SecretariatDirector of the Institutesince 2023

    Responsible for the Institute's output as a whole and for the quarterly assessment cycle. She holds the final editorial decision on register language, and has consistently required that where the Institute does not know…

    Compound Evidence Institute
  • CEI-RG-023SecretariatHead of Analytical Assessmentsince 2024

    Leads the methods series and the review of submitted third-party test data. He compiled the finding, reported across the supplier dossiers, that counter-ion and water determination are absent from essentially the whole…

    Compound Evidence Institute
  • CEI-RG-026SecretariatSenior Assessment Officer, synthesessince 2024

    Drafts the evidence-synthesis series and maintains the amendment logs.

    Compound Evidence Institute
  • CEI-RG-021SecretariatHead of Secretariatsince 2023

    Manages the comment-period process, including the drafting of secretariat responses and the disposition of every submission. The convention that a submission is answered on its substance regardless of the submitter's…

    Compound Evidence Institute
  • CEI-RG-027SecretariatAssessment Officer, supplier dossierssince 2025

    Maintains the supplier dossier series, the correspondence logs and the evaluation scoring against the published rubric.

    Compound Evidence Institute
  • CEI-RG-029SecretariatRegistry and Sitemap Officersince 2025

    Maintains the document registry, the identifier series and the citation-policy implementation.

    Compound Evidence Institute
  • CEI-RG-025SecretariatSenior Assessment Officer, trial abstractssince 2024

    Maintains the structured trial-abstract series and the programme-record convention by which Institute-constructed programme instalments are labelled as such on every page on which they appear.

    Compound Evidence Institute
  • CEI-RG-022SecretariatHead of Evidence Managementsince 2023

    Maintains the reference library and the submitted-evidence log, and is responsible for the rule that a reference the Institute cannot verify against a primary record is either excluded or marked as unverified.

    Compound Evidence Institute
  • CEI-RG-028SecretariatPublications and Corrections Officersince 2024

    Maintains the corrections log and is responsible for ensuring that a correction is published on the document it corrects and not only in the log.

    Compound Evidence Institute
  • CEI-RG-024SecretariatSenior Assessment Officer, monographssince 2024

    Drafts monographs in the incretin and amylin series and maintains the per-indication evidence extracts.

    Compound Evidence Institute
  • CEI-RG-031External reviewersStanding external reviewer, pharmaceuticssince 2024

    Reviews the formulation and stability sections of the monograph series. She authored the position that the Institute should publish no in-use stability claim for reconstituted research material, on the ground that no…

    Reader in Pharmaceutics
  • CEI-RG-136External reviewersExternal reviewer, regulatory sciencesince 2024

    Registered with the Institute as a external reviewer in regulatory science. Contributions are recorded against the documents to which they relate; the Institute publishes no biography beyond affiliation and declared…

    Community pharmacy practice, doctoral…
  • CEI-RG-111External reviewersExternal reviewer, sports medicine and anti-dopingsince 2023

    Registered with the Institute as a external reviewer in sports medicine and anti-doping. Contributions are recorded against the documents to which they relate; the Institute publishes no biography beyond affiliation and…

    Regional hospital pharmacy department
  • CEI-RG-196External reviewersExternal reviewer, clinical pharmacologysince 2025

    Registered with the Institute as a external reviewer in clinical pharmacology. Contributions are recorded against the documents to which they relate; the Institute publishes no biography beyond affiliation and declared…

    Public-sector clinical trials unit
  • CEI-RG-092External reviewersExternal reviewer, analytical chemistrysince 2024

    Registered with the Institute as a external reviewer in analytical chemistry. Contributions are recorded against the documents to which they relate; the Institute publishes no biography beyond affiliation and declared…

    Metabolic medicine service, tertiary centre
  • CEI-RG-041External reviewersExternal reviewer, peptide chemistrysince 2026

    Registered with the Institute as a external reviewer in peptide chemistry. Contributions are recorded against the documents to which they relate; the Institute publishes no biography beyond affiliation and declared…

    Sleep and respiratory medicine service
  • CEI-RG-081External reviewersExternal reviewer, analytical chemistrysince 2024

    Registered with the Institute as a external reviewer in analytical chemistry. Contributions are recorded against the documents to which they relate; the Institute publishes no biography beyond affiliation and declared…

    Community pharmacy practice, doctoral…
  • CEI-RG-037External reviewersStanding external reviewer, analytical methodssince 2023

    Reviews the methods series line by line, including the worked calculations. Every worked example in the methods series has been independently recalculated by him before publication.

    Independent analytical consultant
  • CEI-RG-067External reviewersExternal reviewer, public healthsince 2024

    Registered with the Institute as a external reviewer in public health. Contributions are recorded against the documents to which they relate; the Institute publishes no biography beyond affiliation and declared…

    Academic clinical pharmacology unit
  • CEI-RG-182External reviewersExternal reviewer, public healthsince 2024

    Registered with the Institute as a external reviewer in public health. Contributions are recorded against the documents to which they relate; the Institute publishes no biography beyond affiliation and declared…

    University department of medicinal chemistry
  • CEI-RG-138External reviewersExternal reviewer, peptide chemistrysince 2026

    Registered with the Institute as a external reviewer in peptide chemistry. Contributions are recorded against the documents to which they relate; the Institute publishes no biography beyond affiliation and declared…

    Independent analytical consultancy

page 1 of 6

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.